The global ear and nasal packing market size are estimated to reach ~USD 450 Million by the end of 2035 by growing at a CAGR of ~5% over the forecast period, i.e., 2023 – 2035. In addition to this, in the year 2022, the market size of ear and nasal packing was ~USD 220 Billion. The primary factor for the expansion of the market size during the forecast period is the rising cases of ear and nasal diseases and infections among the global population. Ear and nasal packing are considered vital for the treatment of ear and nasal diseases. Therefore, doctors are using high-quality ear and nasal packing for fast and efficient treatment which in turn is anticipated to bring lucrative growth opportunities for market growth during the forecast period. As per the World Health Organization (WHO), 1 in 4 people in the world is projected to have hearing problems by 2050. Also, as per a report, it is anticipated that nasal infection is estimated to affect around 1 in every 5 people in the United Kingdom in 2035.
Ear and nasal packing are the medical aid solutions that are used post-surgery for controlling bleeding and fast wound healing. This ear and nasal packing are specifically designed for maintaining the patients after nasal surgery such as edema and nose bleed as the polymers have the efficiency of dissolving into the body with a time interval of 2 to 3 weeks. The global ear and nasal packing market are anticipated to increase rapidly grow on the account of rising contagious illnesses among the global population which increases the risk of infection from aerosol and droplet contamination. This is projected to rise the need for ear and nasal packing and expand the market size during the forecast period. Also, the escalation in the awareness level of the advantages of ear and nasal packing along with the technological advancements in the healthcare sector, and the increasing advantages of minimally invasive ENT surgeries are some of the other factors that are projected to create a positive outlook for market growth in the assessment period.
Base Year |
2022 |
Forecast Year |
2023-2035 |
CAGR |
~5% |
Base Year Market Size (2022) |
~ USD 220 Million |
Forecast Year Market Size (2035) |
~ USD 450 Million |
Regional Scope |
|
Growth Drivers
Growing Cases of Chronic Sinusitis – In the recent period, the cases of chronic sinusitis among the global population have risen considerably owing to the rising air pollution and the presence of toxic pollutants in the air. Therefore, the cases of ear and nasal diseases such as chronic sinusitis have increased considerably across the world. As ear and nasal packing are considered to be an effective solution for otolaryngologists and head and neck surgeons for the treatment of sinusitis, the rise in cases of chronic sinusitis is anticipated to increase the demand for ear and nasal packing in the healthcare industry. As per the data shared by the Centers for Disease Control and Prevention (CDC) in 2019, around 11.6% of Americans and 28.9 million adults in the North American region are diagnosed with sinusitis.
Increase in Level of Air Pollution – Owing to rapid urbanization and industrialization, the level of air pollution has considerably grown up in the past years. As a result, people are now being diagnosed with various kinds of ear and nasal infections and diseases. Therefore, this factor is estimated to generate a high demand for ear and nasal packing for effective treatment. Hence, the increasing air pollution over the world is anticipated to bring lucrative growth opportunities for market growth during the analysis period. The data published by the World Health Organization (WHO) stated that almost 90% of the global population breathes air that exceeds WHO guideline limits and contains high levels of pollutants. Further, it is estimated that air pollution is responsible for taking up almost 11.65% of deaths around the world.
High Focus on Developing the Medical Devices Sector - The data revealed by the India Brand Equity Foundation (IBEF) stated that in FY20, the foreign investments in the Indian medical devices sector increased to USD 301 million from USD 151 million in FY19, which indicates a 98% increment.
Rising Focus on Bringing Advancement in the Healthcare Industry - For instance, investment in medical and health research and development (R&D) in the United States (U.S.) increased by 11% to around USD 245 billion in 2020 from previous years.
Rapid Growth in the Healthcare Industry – According to the latest statistics, it is being calculated that the revenue generated by the global healthcare segment was USD 60 billion in 2023 which is further anticipated to grow further.
Challenges
The global ear and nasal packing market is segmented and analyzed for demand and supply by type into bio-absorbable, and non-absorbable. Out of the two types of ear and nasal packing, the bio-absorbable segment is estimated to gain the largest market share of about ~59% in the year 2035. The primary growth factor segment growth is the advantages of bio-absorbable ear and nasal packing over the non-absorbable ear and nasal packing which includes the integration of organic components, natural ingredients, and non-toxic constituents. Moreover, a rising preference for organic products for medical procedures to reduce the risks of on-site infections and other side effects of chemical-based products. All these factors couple up to fuel segment growth during the assessment period.
The global ear and nasal packing market is also segmented and analyzed for demand and supply by end-user into hospitals, specialty clinics, ambulatory centers, and others. Amongst these segments, the hospital segment is expected to garner a significant share of around ~42% in the year 2035. The major factors attributed to the growing segment size are the rising number of hospitals across the globe and the availability of features and facilities for the proper conduction of treatment with ear and nasal packing. For instance, there were over 8,000 hospitals in Japan as of 2020. Korea, by contrast, had about 4,000 hospitals. In addition, there were more than 6000 hospitals in the United States. Also, the preference of hospitals for treatment as the result of trained medical staff and professionals for proper use of ear and nasal packing during surgeries is estimated to expand the segment size in the upcoming years.
Our in-depth analysis of the global ear and nasal packing market includes the following segments:
By Type |
|
By Material |
|
By Product |
|
By End User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this Report
The market share of ear and nasal packing in North America, amongst the market in all the other regions, is projected to be the largest with a share of about ~35% by the end of 2035. The major factor for market growth in the region is the increasing incidences of ear and nose disorders, such as sinus in the region. According to the data from the Centers for Disease Control and Prevention, in the United States, 11.6% of adults were diagnosed with sinusitis in 2020. Moreover, people have easier access to better healthcare facilities, backed by favorable medical reimbursement policies by the government and regulatory bodies which is also estimated to create favorable opportunities for market growth during the assessment period. Further, the presence of a strong healthcare network in the region, with the availability of supportive policies along with the region's expanding healthcare industry and the increasing adoption of healthcare quality management are also anticipated to boost market growth during the forecast period.
The European ear and nasal packing market are estimated to be the second largest, registering a share of about ~24% by the end of 2035. The burgeoning geriatric population who are more prone to ear and nasal diseases in the body and the presence of a large pool of patients in the region are majorly contributing positively to market growth. In addition to other factors, the expansion of ASEAN and Japan digital advertising in pharma and medical equipment is also estimated to increase the awareness level of ear and nasal illnesses and ear and nasal packing among the population and aid the expansion of the market in the region.
Further, the market in the European region, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The factors that are expected to contribute positively to market expansion in the region are rising research and development activities along with the proven success in the development of ear and nasal packing as an efficient treatment method. In addition, the rising prevalence of various types of chronic ear, nose, and throat diseases and disorders among the European people is also estimated to create a favorable outlook for market growth during the forecast period.
Stryker Corporation - Vocera, a part of Stryker Corporation, launched a new wearable, voice-driven device that enables health workers to communicate completely hands-free.
Smith & Nephew plc announced the launch of PICO 7 and PICO 14 negative pressure wound therapy systems, for superficial and deep surgical incisions. The U.S. Food and Drug Administration (FDA) has approved the systems for use on closed surgical incisions.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: The increasing demand for minimally invasive surgeries along with the rising cases of ENT problems are the primary factors that are estimated to boost market growth during the forecast period.
Ans: The market size of ear and nasal packing is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2023 – 2035.
Ans: Lack of awareness about ENT health and care along with the high costs associated with ENT surgical procedures and unavailability of professionals are estimated to be the growth hindering factors for the market expansion.
Ans: The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Ans: The major players in the market are Cerecor, Inc., Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, AbbVie Inc., Smith & Nephew plc, Amgen Inc., Novartis AG, Bayer AG, Progenity, Inc., and other key players.
Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by type, material, product, end user, and by region.
Ans: The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?